Business Context and Reporting Period
This Form 8-K is a current report filed by Bristol-Myers Squibb Company on November 2, 2006. The filing serves as a vehicle to submit XBRL (Extensible Business Reporting Language) formatted documents corresponding to the company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2006.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document explicitly states that the attached XBRL files contain the financial information but are unaudited and intended for testing format and technology. Investors are advised to rely on the official Form 10-Q for actual financial data.
Material Changes
No material changes to financial performance or operations are detailed in this specific 8-K text. The report focuses solely on the procedural submission of XBRL data.
Guidance, Outlook, and Risks
- Management Commentary: The filing includes a disclaimer that the XBRL information is not the official publicly filed financial statement.
- Risks and Contingencies: The document warns that the XBRL data is unaudited and should not be relied upon for investment decisions. It further notes that the information in this 8-K is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liability of that section.
- Unusual Items: The submission is characterized as a test of related format and technology under Rule 401 of Regulation S-T.
Investor Verification Checklist
- Verify the official Form 10-Q filed on November 2, 2006, for audited or official unaudited financial figures.
- Do not use the XBRL documents attached to this 8-K for investment decision-making.
- Confirm that the XBRL data is treated as a technology test rather than a formal filing under Section 18 of the Exchange Act.